Journal article

Lack of clinical activity with crizotinib in a patient with FUS rearranged rhabdomyosarcoma with ALK protein overexpression

Jeremy Lewin, Jayesh Desai, Kortnye Smith, Stephen Luen, Daniel Wong

Pathology | ELSEVIER | Published : 2019


Awarded by Melbourne Genomics Health Alliance

Funding Acknowledgements

The NGS was available through Melbourne Genomics, funded by the State Government of Victoria (Department of Health and Human Services) and the 10 member organisations of the Melbourne Genomics Health Alliance in addition to the Australian Genomics Health Alliance (NHMRC Grant 113531). The authors state that there are no conflicts of interest to disclose.